Trisk Bio

Trisk Bio is a contract development and manufacturing organisation specialising in the production of adeno-associated virus vectors for gene therapy applications.

Its intensified manufacturing processes use suspension bioreactors and chromatography-based purification to deliver high-purity AAV at scalable yields for preclinical and non-human primate studies.

The company serves gene therapy developers globally and has established manufacturing processes for next-generation AI-designed AAV capsids in partnership with Dyno Therapeutics.